Vera Therapeutics Balance Sheet
NASDAQ: VERAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vera Therapeutics financial position
At the end of fiscal 2025, Vera Therapeutics reported total assets of $734.7 million, up 12.1% from a year earlier against total liabilities of $130.2 million. Shareholders' equity stood at $604.5 million, or 82.3% of assets. The company held $354.7 million in cash and equivalents against $74.8 million of debt, a net cash position of $279.9 million.
The current ratio (current assets divided by current liabilities) was 13.64, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.12.
Summary generated from market data by MetaCap's automated system. Methodology
Vera Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 354.73M | 92.65M | 45.68M | 43.46M | 79.67M | 53.65M |
| Short-Term Investments | 359.86M | 548.21M | 115.03M | 71.19M | 0 | — |
| Total Current Assets | 728.88M | 651.22M | 172.02M | 125.70M | 82.54M | 54.26M |
| Property, Plant & Equipment | 1.37M | 960.00K | 92.00K | 51.00K | 0 | — |
| Long-Term Investments | — | — | 11.00K | 58.00K | 867.00K | 0 |
| Total Assets | 734.73M | 655.68M | 175.55M | 131.44M | 83.75M | 54.55M |
| Accounts Payable | 21.90M | 7.67M | 11.12M | 11.99M | 1.39M | 909.00K |
| Total Current Liabilities | 53.45M | 25.37M | 22.30M | 25.60M | 7.69M | 2.41M |
| Long-Term Debt | 74.84M | 50.69M | 49.88M | 24.81M | 4.92M | 0 |
| Total Liabilities | 130.21M | 78.53M | 73.86M | 54.53M | 14.16M | 4.33M |
| Shareholders' Equity | 604.52M | 577.15M | 101.69M | 76.91M | 69.59M | -89.35M |
| Retained Earnings | -760.87M | -461.25M | -309.10M | -213.11M | -124.06M | -91.45M |
| Total Debt | 74.84M | 50.69M | 49.88M | 24.81M | 4.92M | 0 |
| Net Cash (Debt) | 639.75M | 590.16M | 110.84M | 89.84M | 74.75M | 53.65M |
This table shows 6 annual periods of Vera Therapeutics's balance sheet, from FY 2025 back to FY 2020, across 14 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow VERA's reporting calendar. What is a balance sheet?